1st International Multiple Myeloma workshop
01. 04. 2010 – 20. 10. 2010
Brno
Since 2009, we have been able to offer therapeutic regimes with lenalidomide (Revlimid) also to our patients in the Czech Republic, Slovak Republic and Slovenia. I am very glad that the workshop of Celgene company was dedicated exactly to this drug.